Protective effect of prostane in experimental prostatic hyperplasia in rats

Asian Journal of Andrology

Volumn 1, Issue 4, 1999, Pages 175-179

  Mitra, S K ^a   Sundaram, R ^a   Mohan, A R ^a   Gopumadhavan, S ^a   Venkataranganna, M V ^a   Venkatesha, Udupa ^a   Seshadri, S J ^a   Anturlikar, S D ^a  

^a Himalaya Health Care   (India)

Author keywords

Adrenergic alpha antagonists; BPH; Enzyme inhibitors; Hyperplasia; Oxidoreductases; Prostane; Prostate

Indexed keywords

PLANT EXTRACT; PROSTANE, HERBAL PREPARATION;

ANIMAL; ARTICLE; MALE; MEDICINAL PLANT; PHYTOTHERAPY; PROSTATE HYPERTROPHY; RAT; WISTAR RAT;

ANIMALS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PROSTATIC HYPERPLASIA; RATS; RATS, WISTAR;

EID: 0033301293     PISSN: 1008682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Franks LM. Benign prostatic hyperplasia; gross and microscopic anatomy. In: Grayhack JT, Wilson JD, Scherbergke MJ, editors. Benign prostatic hyperplasia. Bethesda, Maryland: National Institute of Health; 1973. p 62-8.
2. Shapiro E, Bechich MJ, Hartanto V. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostatic hyperplasia. J Urol 1992; 147: 1293-7.
3. Joseph EO. LHRH Agonists. A nonsurgical treatment for benign prostatic hyperplasia. J Androl 1991; 12: 381-8.
4. 1-adrenoreceptor antagonists for the treatment of benign prostatic hyperplasia. Eur J Med Chem 1995; 30 Suppl: 299-310.
5. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC. Transurethral prostatectomy; immediate and postoperative complications. A comparative study of 13 participating institutions evaluating 3885 patients. J Urol 1989; 141: 243-7.
6. Singh RG, Singh RP, Usha, Shukla KP, Singh P. Experimental evaluation of diuretic action of herbal drugs Tribulus terrestris Linn on albino rats. J Res Edu Ind Med 1991; 10: 19-21.
7. Sangeetha D, Sidhu H, Thind SK, Nath R. Therapeutic response of Tribulus terrestris, aqueous extract on hyperoxaluria in male adult rats. Phytotherapy Res 1993; 7: 116-9.
8. Ahmed J, Khalid N, Jabeen E. Inhibitory effects of aqueous extracts of natural products on crystallization of urinary lithiasis in vitro. Pak J Scient Indust Res 1987; 30: 205-7.
9. Prasad TNV, Sastry KV. A note on the chemical examination of Pedalium murex leaves. Ind Drugs 1987; 25: 84-5.
10. Nadakami KM. Indian materia medica; v 1. Bombay: Popular Prakashan Private Limited; 1982. p 229.
11. Ashina K, Suzuki K, Aida K, Hibiya T, Tamaoki B. Relationship between the structures and steroidogenic functions of the Urohaze-goby (Glossogobius olivaceus). Gen Comp Endocrinol 1985; 57: 281-92.
12. Peterson RE, Imperato Mc Ginley J, Gautier T. Urinary steroid metabolites in subjects with male pseudo hermaphroditism due to 5α-reductase deficiency. Clin Endocrinol 1985; 23: 45-53.
13. Chen W, Zhou XM, Chen DY, Kang JS. Effects of cimetidine, progesterone, cannitracin and tolozoline on the weight and DNA content of the testosterone-induced hyperplastic prostate of the rat. Urol Res 1988; 16: 363-6.
14. McConnell JD, George FW, Wilson JD, Geller J, Stoner E. The effect of low-dose finasteride (MK-906) on prostatic androgen levels in men with benign prostatic hyperplasia. J Urol 1990; 143 Suppl: 267A.
15. McConnell JD. The pathophysiology of benign prostatic hyperplasia. J Androl 1991; 12: 356-63.
16. Jack Geller. Over view of enzyme inhibitors and antiandrogens in prostatic cancer. J Androl 1991; 12: 361-71.
17. 1-adrenore-ceptors in testosterone-induced prostatic hypertrophy. Eur J Pharmacol 1998; 3-11: 119-26.
18. Bosch RJ, Griffiths DJ, Blom JH, Schroeder FH. Treatment of benign prostatic hyperplasia by androgen deprivation; effects on prostate size and urodynamic parameters. J Urol 1989; 141: 68-72.